封面
市場調查報告書
商品編碼
1716322

2032 年獸醫診斷市場預測:按產品、動物類型、技術、最終用戶和地區進行的全球分析

Veterinary Diagnostics Market Forecasts to 2032 - Global Analysis By Product (Instruments and Consumables), Animal Type, Technology, End User and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據,全球獸醫診斷市場預計在 2025 年達到 40 億美元,到 2032 年將達到 74 億美元,預測期內的複合年成長率為 9.1%。

用於確定動物的疾病、狀況和整體健康狀況的方法和儀器稱為獸醫診斷。它包括影像、分子診斷和實驗室測試,幫助獸醫識別感染疾病、基因異常和其他健康問題。這些診斷對於提供有效的治療、疾病預防和動物福利至關重要。獸醫診斷可實現早期和準確的診斷,從而有助於牲畜管理和伴同性動物護理,有利於食品安全、公共衛生和全球動物保健部門。

根據美國寵物產品協會(APPA)2023年至2024年的調查顯示,美國約有66%的家庭擁有至少一隻寵物,總數約8,690萬戶。

寵物擁有量和支出成長

隨著越來越多的家庭將寵物視為家庭的一部分,他們在寵物健康和福利上花費的錢也在增加。這一趨勢是由對先進診斷設備的需求推動的,以確保快速且準確的疾病診斷。越來越多的飼主開始投資定期檢查和預防性護理。因此,醫院和獸醫診所正在部署先進的診斷工具。由於這種需求的不斷成長,獸醫診斷市場正在不斷成長。

診斷設備高成本

對於許多獸醫診所,特別是農村和開發中地區的獸醫診所來說,先進的診斷設備是遙不可及的。這限制了他們提供快速準確診斷的能力。這會導致治療延遲或無效,對動物保健產生負面影響。高昂的設備成本也可能阻礙對現代診斷技術的投資。這將減緩市場成長,尤其是對於中小型獸醫服務供應商。

遠端醫療和遠距離診斷

這項技術使獸醫能夠遠端諮詢、診斷和監控寵物和牲畜。因此,寵物飼主和農場主人節省了金錢和旅行時間,顧客也變得更加滿意和順從。行動成像設備和穿戴式健康監測器是遠距離診斷技術的例子,它們可以提供即時數據以進行準確評估。遠端醫療的有效性和便利性也有利於更早發現疾病並更頻繁地進行身體檢查。因此,對專門用於虛擬獸醫護理的設備和診斷服務的需求日益成長。

通用感染疾病處理不當的風險

缺乏對通用感染疾病的有效應對會破壞人們對獸醫衛生系統的信任,並阻礙對診斷的投資。應對不充分或延遲可能會導致疾病傳播失控,並增加人類和動物的死亡率。這反過來又破壞了政府和公眾對目前獸醫基礎設施的信心。恐慌和經濟混亂常常導致人們的注意力從預防性診斷轉向緊急應變。監管機構可能會引入抑制創新和市場成長的限制措施。綜合起來,無效的疫情管理將阻礙市場擴張並減少對尖端獸醫診斷的需求。

COVID-19的影響

由於封鎖、獸醫就診次數減少以及供應鏈問題,COVID-19 疫情最初擾亂了獸醫診斷市場。然而,寵物擁有量的增加和人們對通用感染疾病認知的提高刺激了對診斷測試的需求。遠端醫療和照護現場診斷的興起刺激了該領域的創新。加強動物健康和疾病監測凸顯了市場的彈性。總體而言,市場早期遭遇挫折,但隨後強勁復甦,而對動物健康和公共的日益關注也支撐了長期成長。

預計設備部分將成為預測期內最大的部分

在預測期內,由於動物疾病的準確檢測,儀器儀表領域預計將佔據最大的市場佔有率。由於分析和成像設備技術的發展,診斷的效率和可靠性得到了顯著提高。這些工具有助於早期診斷,從而可以更快地進行治療並改善動物的健康狀況。牲畜和寵物飼養需求的不斷成長進一步推動了診斷工具的使用。動物保健基礎設施投資的增加也支持了市場的擴張。

預測期內尿液檢查領域預計將達到最高複合年成長率

尿液檢查領域能夠早期發現動物的各種疾病和糖尿病,預計在預測期內將出現最高的成長率。我們透過提供快速、經濟、非侵入性的診斷技術來改善獸醫護理的結果。隨著寵物擁有量的增加和動物健康知識的提高,對常規尿液檢查的需求也日益成長。自動尿液分析儀的技術發展進一步簡化了診斷過程並提高了準確性。這使得尿液檢查對於預防性醫療保健至關重要,並有助於整個獸醫診斷市場的發展。

佔比最大的地區:

在預測期內,由於寵物飼養量的增加、人們對動物健康的認知的提高以及畜牧業生產的擴大,預計亞太地區將佔據最大的市場佔有率。分子診斷和生物感測器等診斷技術的進步正在增強疾病的檢測和管理。各國政府也在加大動物健康方面的力度,推動及時診斷的需求。中國、印度和日本等主要國家正在推動市場擴張,這得益於其不斷成長的獸醫基礎設施以及針對這一充滿活力地區的全球動物保健公司的投資。

複合年成長率最高的地區:

在預測期內,由於人們對動物健康的認知不斷提高以及診斷技術的進步,預計北美地區將呈現最高的複合年成長率。該地區受益於完善的獸醫基礎設施、高額的伴同性動物醫療保健支出以及日益成長的早期疾病檢測需求。主要市場相關人員正在投資分子診斷和就地檢驗等創新診斷工具。畜牧業也以疾病控制和食品安全為重點,為市場擴張做出了貢獻。美國在該地區佔有最大的市場佔有率。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一:

  • 公司簡介
    • 對其他市場公司(最多 3 家公司)進行全面分析
    • 主要企業的SWOT分析(最多3家公司)
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率(註:基於可行性檢查)
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 初級研究資訊來源
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球獸醫診斷市場(按產品)

  • 裝置
    • 血液分析儀
    • 生化分析設備
    • 免疫診斷分析儀
    • 分子診斷設備
  • 耗材
    • 試劑
    • 檢測套組
    • 控制板

6. 全球獸醫診斷市場(依動物類型)

  • 伴同性動物
  • 生產動物
    • 家禽
    • 綿羊和山羊

7. 全球獸醫診斷市場(按技術)

  • 免疫診斷
    • 酵素免疫分析法(ELISA)
    • 橫向流動化驗
    • 快速檢測
  • 臨床生物化學
    • 血糖監測
    • 電解質分析
  • 分子診斷
    • 聚合酵素鏈鎖反應(PCR)
    • 微陣列
    • 核酸序列分析
  • 血液學
  • 尿液檢查
  • 微生物學
  • 其他技術

8. 全球獸醫診斷市場(依最終用戶)

  • 獸醫診所
  • 參考實驗室
  • 內部測試
  • 科學研究機構和大學
  • 其他最終用戶

9. 全球獸醫診斷市場(按地區)

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • IDEXX Laboratories, Inc.
  • Zoetis Services LLC
  • Heska Corporation
  • Thermo Fisher Scientific Inc.
  • Avante Animal Health
  • Virbac
  • Randox Laboratories Ltd.
  • VCA Animal Hospitals
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Antech Diagnostics, Inc.
  • Agrolabo SpA
  • Embark Veterinary, Inc.
  • Esaote SPA
  • Innovative Diagnostics SAS
  • FUJIFILM Corporation
  • Neogen Corporation
  • Bio-Rad Laboratories, Inc.
  • INDICAL Bioscience GmbH
Product Code: SMRC29133

According to Stratistics MRC, the Global Veterinary Diagnostics Market is accounted for $4.0 billion in 2025 and is expected to reach $7.4 billion by 2032 growing at a CAGR of 9.1% during the forecast period. The methods and equipment used to determine an animal's illness, condition, and general state of health are referred to as veterinary diagnostics. It consists of imaging, molecular diagnostics, and laboratory testing that assist veterinarians in identifying infections, genetic abnormalities, and other health problems. In order to provide efficient treatment, illness prevention, and animal welfare, these diagnostics are essential. Veterinary diagnostics help livestock management and companion animal care by facilitating early and accurate diagnosis, which benefits food safety, public health, and the global animal healthcare sector.

According to the American Pet Products Association (APPA) study conducted between 2023 and 2024, approximately 66% of households in the U.S. have at least one pet, totaling around 86.9 million households.

Market Dynamics:

Driver:

Growth in pet ownership and expenditure

The amount spent on pets' health and wellbeing has increased as more homes consider them members of the family. The need for sophisticated diagnostic instruments to guarantee prompt and precise illness diagnosis is fuelled by this trend. More and more pet owners are prepared to spend money on routine examinations and preventive care. As a result, hospitals and veterinary clinics are implementing advanced diagnostic tools. The market for veterinary diagnostics is growing as a direct result of this increase in demand.

Restraint:

High cost of diagnostic equipment

Advanced diagnostic equipment is out of reach for many veterinary clinics, particularly those in rural or developing areas. This restricts their capacity to provide prompt and precise diagnosis. As a result, delayed or ineffective therapies negatively impact animal healthcare. Investment in contemporary diagnostic methods is sometimes deterred by high equipment prices. This slows down market growth, especially for small and mid-sized veterinary service providers.

Opportunity:

Telemedicine and remote diagnostics

Veterinarians can now consult, diagnose, and keep an eye on pets and livestock remotely thanks to this technology. Pet owners and farm managers save money and travel time as a result, increasing customer happiness and compliance. Mobile imaging equipment and wearable health monitors are examples of remote diagnostics technologies that offer real-time data for precise evaluations. Early disease detection and more frequent checkups are also encouraged by the effectiveness and convenience of telemedicine. Consequently, the need for instruments and diagnostic services specifically designed for virtual veterinarian care is increasing.

Threat:

Risk of zoonotic outbreak mismanagement

Ineffective handling of zoonotic outbreaks erodes confidence in veterinary healthcare systems and discourages diagnostic investment. Inadequate or delayed reactions may result in unchecked disease transmission, raising both human and animal mortality. Government and public trust in the current veterinary infrastructure is damaged as a result. Focus frequently shifts from preventive diagnosis to emergency response as a result of the ensuing panic and economic upheaval. Regulations may be put in place by regulatory agencies that hinder innovation and market growth. All things considered, ineffective outbreak management stunts expansion and reduces demand for cutting-edge veterinary diagnostics.

Covid-19 Impact

The COVID-19 pandemic disrupted the veterinary diagnostics market initially due to lockdowns, reduced veterinary visits, and supply chain issues. However, increased pet adoption and growing awareness of zoonotic diseases fueled demand for diagnostic testing. Telemedicine and point-of-care diagnostics gained traction, driving innovation in the sector. Research on animal health and disease surveillance intensified, highlighting the market's resilience. Overall, while the market faced early setbacks, it rebounded strongly, with long-term growth supported by heightened focus on animal health and public safety.

The instruments segment is expected to be the largest during the forecast period

The instruments segment is expected to account for the largest market share during the forecast period, due to accurate disease detection in animals. The efficiency and dependability of diagnosis have been greatly increased by technological developments in analysers and imaging equipment. These tools facilitate early diagnosis, allowing for prompt treatment and better results for the health of the animals. The usage of diagnostic tools is further fuelled by increased livestock production demands and pet ownership. The expansion of this market is also supported by more investments in the infrastructure of veterinary healthcare.

The urinalysis segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the urinalysis segment is predicted to witness the highest growth rate, due to by enabling early detection of various diseases and diabetes in animals. It improves the effectiveness of veterinary care by providing a quick, affordable, and non-invasive diagnostic technique. The need for routine urine testing is being driven by rising pet ownership and greater knowledge of animal health. Further streamlining diagnostic processes and increasing accuracy are technological developments in automated urine analysers. Because of this, urinalysis is essential to preventative healthcare and helps the veterinary diagnostics market as a whole.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising pet ownership, increasing awareness of animal health, and expanding livestock production. Advancements in diagnostic technologies, such as molecular diagnostics and biosensors, are enhancing disease detection and management. Governments are also strengthening animal health initiatives, boosting demand for timely diagnostics. Key countries like China, India, and Japan are driving market expansion, supported by growing veterinary infrastructure and investment from global animal health companies targeting this dynamic region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, due to rising awareness of animal health, and advancements in diagnostic technologies. The region benefits from well-established veterinary infrastructure, high healthcare expenditure on companion animals, and a growing demand for early disease detection. Key market players are investing in innovative diagnostic tools, including molecular diagnostics and point-of-care testing. The livestock sector also contributes to market expansion, with emphasis on disease control and food safety. The United States holds the largest market share in the region.

Key players in the market

Some of the key players profiled in the Veterinary Diagnostics Market include IDEXX Laboratories, Inc., Zoetis Services LLC, Heska Corporation, Thermo Fisher Scientific Inc., Avante Animal Health, Virbac, Randox Laboratories Ltd., VCA Animal Hospitals, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Antech Diagnostics, Inc., Agrolabo S.p.A., Embark Veterinary, Inc., Esaote SPA, Innovative Diagnostics SAS, FUJIFILM Corporation, Neogen Corporation, Bio-Rad Laboratories, Inc., INDICAL Bioscience GmbH

Key Developments:

In February 2024, IDEXX enhanced VetConnect PLUS(R), enabling veterinarians to access reference lab sample turnaround times and order status information. Additionally, IDEXX DecisionIQ(TM), integrated within VetConnect PLUS(R), provides AI-driven clinical decision support for conditions like vector-borne diseases, chronic kidney disease, and endocrine disorders.

In August 2023, Zoetis launched Vetscan Mastigram+, a rapid on-farm mastitis diagnostic tool in several European markets. This product enables farmers and veterinarians to detect Gram-positive mastitis in cows within 8 hours, facilitating targeted antimicrobial therapy.

In January 2023, IDEXX launched a new diagnostic test for kidney injury in cats and dogs, enhancing its renal testing portfolio. This innovation helps veterinarians detect kidney damage earlier, improving treatment outcomes and advancing IDEXX's commitment to providing comprehensive, accurate diagnostic solutions for veterinary care.

Products Covered:

  • Instruments
  • Consumables

Animal Types Covered:

  • Companion Animals
  • Production Animals

Technologies Covered:

  • Immunodiagnostics
  • Clinical Biochemistry
  • Molecular Diagnostics
  • Hematology
  • Urinalysis
  • Microbiology
  • Other Technologies

End Users Covered:

  • Veterinary Hospitals & Clinics
  • Reference Laboratories
  • In-House Testing
  • Research Institutes & Universities
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.1 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Veterinary Diagnostics Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
    • 5.2.1 Hematology analyzers
    • 5.2.2 Biochemistry analyzers
    • 5.2.3 Immunodiagnostic analyzers
    • 5.2.4 Molecular diagnostic instruments
  • 5.3 Consumables
    • 5.3.1 Reagents
    • 5.3.2 Test kits
    • 5.3.3 Panels
    • 5.3.4 Strips

6 Global Veterinary Diagnostics Market, By Animal Type

  • 6.1 Introduction
  • 6.2 Companion Animals
    • 6.2.1 Dogs
    • 6.2.2 Cats
    • 6.2.3 Horses
  • 6.3 Production Animals
    • 6.3.1 Cattle
    • 6.3.2 Swine
    • 6.3.3 Poultry
    • 6.3.4 Sheep & Goats

7 Global Veterinary Diagnostics Market, By Technology

  • 7.1 Introduction
  • 7.2 Immunodiagnostics
    • 7.2.1 Enzyme-linked Immunosorbent Assay (ELISA)
    • 7.2.2 Lateral Flow Assays
    • 7.2.3 Rapid Tests
  • 7.3 Clinical Biochemistry
    • 7.3.1 Glucose monitoring
    • 7.3.2 Electrolyte analysis
  • 7.4 Molecular Diagnostics
    • 7.4.1 Polymerase Chain Reaction (PCR)
    • 7.4.2 Microarrays
    • 7.4.3 Nucleic Acid Sequencing
  • 7.5 Hematology
  • 7.6 Urinalysis
  • 7.7 Microbiology
  • 7.8 Other Technologies

8 Global Veterinary Diagnostics Market, By End User

  • 8.1 Introduction
  • 8.2 Veterinary Hospitals & Clinics
  • 8.3 Reference Laboratories
  • 8.4 In-House Testing
  • 8.5 Research Institutes & Universities
  • 8.6 Other End Users

9 Global Veterinary Diagnostics Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 IDEXX Laboratories, Inc.
  • 11.2 Zoetis Services LLC
  • 11.3 Heska Corporation
  • 11.4 Thermo Fisher Scientific Inc.
  • 11.5 Avante Animal Health
  • 11.6 Virbac
  • 11.7 Randox Laboratories Ltd.
  • 11.8 VCA Animal Hospitals
  • 11.9 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 11.10 Antech Diagnostics, Inc.
  • 11.11 Agrolabo S.p.A.
  • 11.12 Embark Veterinary, Inc.
  • 11.13 Esaote SPA
  • 11.14 Innovative Diagnostics SAS
  • 11.15 FUJIFILM Corporation
  • 11.16 Neogen Corporation
  • 11.17 Bio-Rad Laboratories, Inc.
  • 11.18 INDICAL Bioscience GmbH

List of Tables

  • Table 1 Global Veterinary Diagnostics Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Veterinary Diagnostics Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Veterinary Diagnostics Market Outlook, By Instruments (2024-2032) ($MN)
  • Table 4 Global Veterinary Diagnostics Market Outlook, By Hematology analyzers (2024-2032) ($MN)
  • Table 5 Global Veterinary Diagnostics Market Outlook, By Biochemistry analyzers (2024-2032) ($MN)
  • Table 6 Global Veterinary Diagnostics Market Outlook, By Immunodiagnostic analyzers (2024-2032) ($MN)
  • Table 7 Global Veterinary Diagnostics Market Outlook, By Molecular diagnostic instruments (2024-2032) ($MN)
  • Table 8 Global Veterinary Diagnostics Market Outlook, By Consumables (2024-2032) ($MN)
  • Table 9 Global Veterinary Diagnostics Market Outlook, By Reagents (2024-2032) ($MN)
  • Table 10 Global Veterinary Diagnostics Market Outlook, By Test kits (2024-2032) ($MN)
  • Table 11 Global Veterinary Diagnostics Market Outlook, By Panels (2024-2032) ($MN)
  • Table 12 Global Veterinary Diagnostics Market Outlook, By Strips (2024-2032) ($MN)
  • Table 13 Global Veterinary Diagnostics Market Outlook, By Animal Type (2024-2032) ($MN)
  • Table 14 Global Veterinary Diagnostics Market Outlook, By Companion Animals (2024-2032) ($MN)
  • Table 15 Global Veterinary Diagnostics Market Outlook, By Dogs (2024-2032) ($MN)
  • Table 16 Global Veterinary Diagnostics Market Outlook, By Cats (2024-2032) ($MN)
  • Table 17 Global Veterinary Diagnostics Market Outlook, By Horses (2024-2032) ($MN)
  • Table 18 Global Veterinary Diagnostics Market Outlook, By Production Animals (2024-2032) ($MN)
  • Table 19 Global Veterinary Diagnostics Market Outlook, By Cattle (2024-2032) ($MN)
  • Table 20 Global Veterinary Diagnostics Market Outlook, By Swine (2024-2032) ($MN)
  • Table 21 Global Veterinary Diagnostics Market Outlook, By Poultry (2024-2032) ($MN)
  • Table 22 Global Veterinary Diagnostics Market Outlook, By Sheep & Goats (2024-2032) ($MN)
  • Table 23 Global Veterinary Diagnostics Market Outlook, By Technology (2024-2032) ($MN)
  • Table 24 Global Veterinary Diagnostics Market Outlook, By Immunodiagnostics (2024-2032) ($MN)
  • Table 25 Global Veterinary Diagnostics Market Outlook, By Enzyme-linked Immunosorbent Assay (ELISA) (2024-2032) ($MN)
  • Table 26 Global Veterinary Diagnostics Market Outlook, By Lateral Flow Assays (2024-2032) ($MN)
  • Table 27 Global Veterinary Diagnostics Market Outlook, By Rapid Tests (2024-2032) ($MN)
  • Table 28 Global Veterinary Diagnostics Market Outlook, By Clinical Biochemistry (2024-2032) ($MN)
  • Table 29 Global Veterinary Diagnostics Market Outlook, By Glucose monitoring (2024-2032) ($MN)
  • Table 30 Global Veterinary Diagnostics Market Outlook, By Electrolyte analysis (2024-2032) ($MN)
  • Table 31 Global Veterinary Diagnostics Market Outlook, By Molecular Diagnostics (2024-2032) ($MN)
  • Table 32 Global Veterinary Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2024-2032) ($MN)
  • Table 33 Global Veterinary Diagnostics Market Outlook, By Microarrays (2024-2032) ($MN)
  • Table 34 Global Veterinary Diagnostics Market Outlook, By Nucleic Acid Sequencing (2024-2032) ($MN)
  • Table 35 Global Veterinary Diagnostics Market Outlook, By Hematology (2024-2032) ($MN)
  • Table 36 Global Veterinary Diagnostics Market Outlook, By Urinalysis (2024-2032) ($MN)
  • Table 37 Global Veterinary Diagnostics Market Outlook, By Microbiology (2024-2032) ($MN)
  • Table 38 Global Veterinary Diagnostics Market Outlook, By Other Technologies (2024-2032) ($MN)
  • Table 39 Global Veterinary Diagnostics Market Outlook, By End User (2024-2032) ($MN)
  • Table 40 Global Veterinary Diagnostics Market Outlook, By Veterinary Hospitals & Clinics (2024-2032) ($MN)
  • Table 41 Global Veterinary Diagnostics Market Outlook, By Reference Laboratories (2024-2032) ($MN)
  • Table 42 Global Veterinary Diagnostics Market Outlook, By In-House Testing (2024-2032) ($MN)
  • Table 43 Global Veterinary Diagnostics Market Outlook, By Research Institutes & Universities (2024-2032) ($MN)
  • Table 44 Global Veterinary Diagnostics Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.